MAPT and Alzheimer disease: CSF contactin-2 correlated with tTau and pTau within the AD/control groups, being stronger within the control group, which suggests that contactin-2 is a sensitive marker reflecting general axonal loss and changes in tau homeostasis under normal physiological conditions.